Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC00678 (long intergenic non-protein coding RNA 678) is a human gene that encodes a long intergenic non-coding RNA (lincRNA) transcript. lincRNAs are defined as autonomously transcribed RNA molecules longer than 200 nucleotides that do not overlap protein-coding genes. They participate in diverse aspects of cell biology including chromatin remodeling, gene regulation (either locally or distantly), and possibly enhancer-like activity, with high tissue specificity. While many lincRNAs have been linked to diseases such as cancer and developmental disorders, the specific cellular role of LINC00678 itself remains unclear. Its expression may be involved in cell differentiation pathways, as its transcript levels can change during differentiation, but detailed mechanistic or disease associations have not been ascribed to this gene. LINC00678 is not a protein and does not serve as a classical drug target, receptor, enzyme, or transporter, but may have regulatory or biomarker potential in human health and disease.
Not applicable. As no drugs targeting LINC00678 exist, mechanisms of action cannot be assigned
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 678 (LINC00678).